ECMO support during high-risk TAVR heart valve procedure
Part of Heart & circulation clinical trials.
This trial tests whether placing patients on ECMO (a heart-lung support machine) before a high-risk TAVR valve replacement can improve safety and outcomes. It is for people who are at very high risk due to low blood pressure, severe heart or lung problems, or complex valve anatomy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and not pregnant.
- You need to have either severely low blood pressure or signs of shock, OR you have complex heart anatomy that makes the valve procedure risky.
- You must not have severe blockages in leg arteries that prevent ECMO use.
- You must not have had a cardiac arrest that required CPR for over 40 minutes.
- This trial is not for people who are stable or have simple valve anatomy with low risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a procedure called TAVI (a valve replacement done through a tube in the leg) can help people with severe aortic stenosis who are in cardiogenic shock, a dangerous condition where the heart can't pump enough blood. The goal is to see if urgent valve replacement improves survival.
This trial tests if a heart valve replacement procedure called TAVI can be safely done at heart centers that do not have a full heart surgery team available onsite. It is for people with severe narrowing of the aortic valve who are already planned for TAVI through the leg artery.
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
This trial studies a faster, emergency version of a valve replacement done through the blood vessels (TAVI) for people with severe aortic valve narrowing. It aims to check whether this approach is safe and works when people are in urgent, hard-to-stabilize situations.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study looks at how safe and effective an emergency heart valve replacement is for people with severe aortic stenosis who are in critical condition. It may help if you have severe symptoms like shock or unstable chest pain that need urgent treatment.
Hear when a new Severe Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.